SCHEMBL20124974

SCHEMBL20124974

Cc1cnc(N)c(C=O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 3/20 0.54
NOS2 P35228 3/20 0.54
NOS1 P29475 2/20 0.54
ERN1 O75460 2/20 0.43
SRC P12931 2/20 0.39
CYP2A6 P11509 2/20 0.39
ALDH1A1 P00352 4/20 0.37
LMNA P02545 1/20 0.37
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
IKBKB O14920 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
MPI P34949 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
OPRK1 P41145 2/20 0.32
LRRK2 Q5S007 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20125043 0.79 NOS3 (0.54) NOS3NOS2NOS1CYP2A6CCR1
SCHEMBL8296665 0.79 NOS3 (0.54) NOS3NOS2NOS1CYP2A6CCR1
SCHEMBL6626617 0.78 ERN1 (0.46) NOS3NOS2NOS1ERN1SRC
SCHEMBL29952796 0.78 ERN1 (0.46) NOS3NOS2NOS1ERN1SRC
SCHEMBL8341853 0.76 NOS3 (0.50) NOS3NOS2NOS1CYP2A6CCR1
SCHEMBL24609208 0.75 HTT (0.30) NOS3NOS2NOS1KMT2A
SCHEMBL4640515 0.75 ERN1 (0.43) NOS3NOS2NOS1ERN1SRC
SCHEMBL6856791 0.75 HTT (0.30) NOS3NOS2NOS1KMT2A
SCHEMBL124567 0.75 KMT2A (0.54) ERN1ALDH1A1MEN1MAPTKMT2A
SCHEMBL247814 0.75 ERN1 (0.39) NOS3NOS2NOS1ERN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024178390-A1 COVALENT MODIFIERS OF AKT1 AND USES THEREOF TERREMOTO BIOSCIENCES, INC. (US) 2024-08-29 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
WO-2022140456-A1 SUBSTITUTED AMINOBENZYL HETEROARYL COMPOUNDS AS EGFR AND/OR PI3K INHIBITORS MEKANISTIC THERAPEUTICS LLC (US) 2022-06-30 WO disclosed
EP-3831824-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) 2021-06-09 EP disclosed
WO-2020024997-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION 上海轶诺药业有限公司 2020-02-06 WO disclosed
EP-3318557-A2 QUINOLONE COMPOUND Otsuka Pharmaceutical Co., Ltd. (JP) 2018-05-09 EP disclosed